Compare DexCom, Inc. (DXCM) vs Occidental Petroleum Corporation (OXY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Occidental Petroleum Corporation — how do they compare? DexCom, Inc. trades at $77.28 (market cap $28.06B), while Occidental Petroleum Corporation trades at $53.7 (market cap $53.48B). The key difference: Occidental Petroleum Corporation is the larger of the two by market cap, and Occidental Petroleum Corporation pays a 1.93% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | OXY | |
|---|---|---|
Market Cap | $28.06B | $53.48B |
Sector | Health | Energy |
52-Week High | $89.53 | $66.24 |
52-Week Low | $54.84 | $38.92 |
Enterprise Value | $27.03B | $74.57B |
Dividend Yield | — | 1.93% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DXCM trades at $77.31, up 4.3% on the day, with a bullish technical outlook as it approaches resistance near $78. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.56 surpassing expectations of $0.47. Revenue growth accelerated to $4.66 billion in 2025, while net income margin expanded to 17.93%. Recent regulatory approvals, including Health Canada authorization for the G7 15-day CGM, support continued international expansion.
The stock offers growth potential with analyst consensus price target of $84.33, though high valuation multiples (P/E 31.21) and competition in the CGM market present risks. Expansion into non-insulin Type 2 diabetes and pediatric markets could drive future revenue, but commercial uptake remains unproven. Institutional sentiment remains strongly bullish with 80% buy ratings.
Occidental Petroleum (OXY) trades at $54.02, down 1.01% on the day, with a bullish technical signal supported by moving averages. The company has beaten earnings estimates for three consecutive quarters, with Q2 2026 results expected on August 5. Recent news highlights improved capital efficiency and debt reduction, while analyst consensus shows 50% buy ratings with a $66.14 price target. Revenue has declined from $36.6B in 2022 to $21.6B in 2025, though net margins remain healthy at 10.77%.
OXY presents a mixed outlook with strong operational performance and analyst optimism offset by declining revenue trends. The stock offers potential upside to consensus targets but faces risks from oil price volatility and execution challenges under new leadership. Key catalysts include Q2 earnings and continued progress on debt reduction initiatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Occidental Petroleum Corporation
Occidental Petroleum is an independent exploration and production company with operations in the United States, Latin America, and the Middle East. At the end of 2021, the company reported net proved reserves of 3.5 billion barrels of oil equivalent. Net production averaged 1,174 thousand barrels of oil equivalent per day in 2021 at a ratio of 75% oil and natural gas liquids and 25% natural gas.
Read more on OXY →
